Sohini Sengupta

Sohini Sengupta

Auto-generated profile, based on publicly available information

Sohini Sengupta

Clinical Biochemistry & Laboratory Services, BLK Super Speciality Hospital, Delhi, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2021 in Indian Journal of Clinical Biochemistry
Verified
Journal Article
Closed access
PDF file
SSSohini Sengupta
Sohini Sengupta
AHAnil Handoo
Anil Handoo
IHInaamul Haq
Inaamul Haq
KDKaramvir Dahiya
Karamvir Dahiya
SMSanjay Mehta
Sanjay Mehta
MKMradul Kaushik
Mradul Kaushik

31 January 2017 in International Journal of Medical Research & Review
Verified
Journal Article
Open access
PDF file
SNSohini Sengupta Neogi
Sohini Sengupta Neogi
RKRaj Kumar Kapoor
Raj Kumar Kapoor
In the Emergency Department cardiac troponins are the preferred biomarkers for the diagnosis of acute myocardial infarction (MI) and are useful for risk stratification of patients with acute coronary syndrome (ACS) and stable ischemic heart disease. The introduction of ‘high sensitivity’ Troponins (hscTn) in many tertiary care centers has transformed the diagnostic scenario, wherein, the time from onset of chest pain to its diagnosis has significantly been reduced. With the advent of new hsTnI assays, which have a low limit of detection, low imprecision and low reference limits, the possibility of more patients with unstable angina being classified as having non-ST-elevation myocardial infarction (NSTEMI) will now increase. Its use will identify more high-risk patients with undifferentiated chest pain, that will help ‘rule-in’ or ‘rule-out’ acute myocardial infarction. In conclusion, it may be said that hsTropI is a sensitive, albeit less specific marker of MI. In patients of mildly elevated hsTropI and without evidence of ST elevation, a serial assessment of the biomarker is suggested. This will likely translate into more improved outcomes in this difficult patient population when ECG findings and clinical presentation do not suggest a clear diagnosis.

27 July 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
Beifang NiuBeifang Niu
Beifang Niu
ASAdam D Scott
Adam D Scott
SSSohini Sengupta
Sohini Sengupta
MBMatthew H Bailey
Matthew H Bailey
PBPrag Batra
Prag Batra
LDLi Ding
Li Ding
Nat. Genet. 48, 827–837 (2016); published online 13 June 2016; corrected after print 20 March 2017 In the version of this article initially published, residue R384 was incorrectly highlighted in the protein model depicted in Figure 7e. The correct residue is R394. The error has been corrected in theHTML and PDF versions of the article.

19 March 2021
Verified
Conference Paper
Closed access
MAMohamed Adam
Mohamed Adam
CCC Conlon
C Conlon
SDS Doing
S Doing
JMJ Morris
J Morris
BVB Vankeesan
B Vankeesan
JKJ Keohane
J Keohane
Aims The aims of this study were to assess the correlation between abnormal imaging and endoscopic findings. Methods A retrospective descriptive study was performed. All patients referred with abnormal radiology as the indication for lower GI endoscopy in Louth County Hospital (LCH) between 2013 and August 2020 were included. Data, including; patient demographics, the modality of imaging, results of imaging, indication for endoscopy, and results of endoscopy were collected using electronic patient records. Endoscopic findings were compared with radiology reports. Results A total of 209 lower GI endoscopies, (172 colonoscopies and 37 sigmoidoscopies) were performed in LCH between 2013 and August 2020 for the indication of abnormal radiology, 51 % (n = 108) were male. The mean interval from imaging to colonoscopy was 86.3 days (Range 13-218 days). 81 % (n = 170) of imaging modalities employed were CT scans. The mean interval from imaging to sigmoidoscopy was 128 days (range 11 days to 823 days). CT Colon accounted for 51 % (n = 19) of the imaging modalities employed. In Our patient cohort 71 % of endoscopic findings correlated with radiology. Conclusions The most common abnormality on radiology referred for lower GI endoscopy was diverticulitis. A tumour was identified endoscopically in one of these patients. No other suspicious endoscopic findings were detected. The need for endoscopy post an episode of uncomplicated diverticulitis without suspicious features is questionable. Current practice guidelines do not recommend routine endoscopy post uncomplicated diverticulitis. In some studies, the risk of advanced neoplasia post uncomplicated diverticulitis is equivalent to the risk of colorectal cancer in the general population. 59 % of radiology findings suggestive of thickening, colitis, or strictures correlated with endoscopic findings. In the appropriate clinical context, not all patients with such features on radiology require endoscopic and histological diagnoses. Further assessment is recommended to identify specific imaging abnormalities that benefit from endoscopy allowing appropriate use of our limited resources. Citation Adam M, Conlon C, Doing S et al. eP129 IS ABNORMAL RADIOLOGY A GOOD PREDICTOR OF ENDOSCOPIC FINDINGS?. Endoscopy 2021; 53: S139. Publication Date: 19 March 2021 (online) © 2021. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

1 March 2020 in Point of Care: The Journal of Near-Patient Testing & Technology
Verified
Journal Article
Closed access
SSSohini Md Sengupta
Sohini Md Sengupta
AHAnil Handoo
Anil Handoo
With testing in health care becoming more decentralized to include the patient bedside, quality assurance in point-of-care testing (POCT) assumes immense significance in optimizing clinical outcomes. However, complex regulatory requirements, training of testing personnel, and implementation of a uniform quality policy in varied locations across the hospital pose the greatest challenges in achieving the desired result. Although 70 POCT instruments were being used across our hospital, there was no structured program in place. In accordance with the requirements of the Joint Commission (JCI) accreditation, efforts were made to bring the supervision of POCT under the supervision of the laboratory. Initial internal audits revealed absence of quality assurance policies, inadequate documentation, and lack of uniformity in POCT practices across the hospital. Standard operating procedures on uniform POCT practice, quality control, and critical values were formulated. Training of testing personnel was conducted. Internal quality control and proficiency testing programs were designed and implemented. Periodic evaluation revealed a paradigm shift in the attitude of the testing personnel and the treating physicians toward POCT. It helped in ensuring strict adherence to quality practices in POCT and increased confidence in the reported results. This impacted positive clinical outcomes. Although, on one hand, the implementation of a structured POCT program facilitated the accreditation by the Joint Commission, it also helped us achieve uniformity and a high level of quality in POCT across the hospital. A multidisciplinary organizational approach for POCT under the direct supervision of the laboratory improved the quality of patient care.